ALL
Feature
Young children with leukemia are outliving teens
Two new studies spotlight age disparities that continue to plague blood cancer care.
Conference Coverage
Many die waiting for `last-chance’ therapy
Blood cancer patients, especially those with myeloma, face hospice and death while awaiting CAR T-cell therapy.
Feature
CAR T-cell therapy turns 10 and finally earns the word ‘cure’
“We have a couple dozen patients who are 5, 6, 7, 9 years out or more without further therapy. That feels like a cure to me.”
Feature
Drug shortages plague hematology, but preparedness helps
The plight of desperate patients is getting attention – and some remedies.
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
From the Journals
Young leukemia survivors still dying early, study shows
‘Cure is not enough’ for adolescent and young adult survivors of leukemia, with new data indicating that their life spans are still cut short.
Feature
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
Feature
Rare pediatric cancers persist 63 years after nuclear accident
Near Los Angeles, the parents of kids whose cluster of rare leukemias and other cancers may be linked to a 1959 partial meltdown at Santa Susana...
From the Journals
CLL patients ‘cured’: 10 years post infusion, CAR T cells persist
A decade after CAR T’cell treatment, chronic leukemia patients reported “cured,” with cells still detectable.
Feature
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
Feature
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”